Global Surgical Chips Market Research Report- Forecast To 2027

Global Surgical Chips Market Information, by types (DNA Chips, brain chips, lab chips, protein chips, tissue chip) by  application (Cancer Diagnosis and Treatment, Gene Expression, SNP Genotyping, Genomics, Clinical Diagnostics) by end users (hospitals,  research centers, clinics, others) - Forecast to 2027

ID: MRFR/MED/0802-HCR | February 2021 | Region: Global | 110 pages

 Market Synopsis of Surgical Chips Market:


Market Scenario:


A surgical chip is a recognizing coordinated circuit gadget / RFID transponder encased in silicate glass and embedded in the body of a person. A sub dermal implant ordinarily contains an exceptional ID number that can be connected to data contained in an outside database, for example, individual recognizable proof, medicinal history, meds, allergies, and contact information. The global market for Surgical Chips is expected to reach US$ XX by the end of the forecasted period and is expected to grow at a CAGR of XX%


Study Objectives of Surgical Chips Market:


  · To provide detailed analysis of the market structure along with forecast for the next 10 years of the various segments and sub-segments of the Surgical Chips  market 


· To provide insights about factors affecting the market growth


· To analyze the Surgical Chips market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.


· To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.


· To provide country level analysis of the market with respect to the current market size and future prospective


· To provide country level analysis of the market for segments by type, by application, by end users and its sub-segments


· To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market


· To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Surgical Chips market.


Intended Audience



  • ·Surgical Chips manufacturers

  • ·Surgical Chips Suppliers

  • ·Research and Development (R&D) Companies

  • ·Medical Research Laboratories

  • ·Academic Medical Institutes and Universities


Key Players for Surgical Chips Market:


Some of the key players in this market are: Abbott Laboratories (US) Agilent Technologies, Inc. (US) Perkinelmer, Inc. (US) Fluidigm Corporation (US) Illumina, Inc. (US) GE Healthcare (UK)  Bio-Rad Laboratories Inc. (US)  Cepheid (US),  Thermo Fisher Scientific, Inc. (US)  Roche Diagnostics (Switzerland)


Segments:


 


Global Surgical Chips market has been segmented on the basis of types which comprises of DNA Chips, brain chips, lab chips, protein chips, tissue chip and others. On the basis of end users which consists of hospitals, clinics, research facilities and others. On the basis of application which consists of Cancer Diagnosis and Treatment, Gene Expression, SNP Genotyping, Genomics, Clinical Diagnostics and others


Regional Analysis of Surgical Chips Market:


Globally North America is the largest market for Surgical Chips. The North American market for Surgical Chips is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. This is due to increasing healthcare R&D expenditure and improvement of healthcare technology. Europe is the second-largest market for Surgical Chips which is expected to grow at a CAGR of XX%. Whereas Asia pacific is expected to be a growing market for Surgical Chips market


 


The report for Global Surgical Chips


 Global Surgical Chips market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant value
  CAGR   2020–2027: Substantial CAGR
  Base Year   2019
  Forecast Period   2027
  Historical Data   2017- 2018
  Forecast Units   Value (USD Million)
  Report Coverage    Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Types, By Application, By End Users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abbott Laboratories (US) Agilent Technologies, Inc. (US) Perkinelmer, Inc. (US) Fluidigm Corporation (US) Illumina, Inc. (US) GE Healthcare (UK) Bio-Rad Laboratories Inc. (US) Cepheid (US), Thermo Fisher Scientific, Inc. (US) Roche Diagnostics (Switzerland)
  Key Market Opportunities   To analyze the Surgical Chips market based on various factors- price analysis, supply chain analysis, porters five force analysis etc
  Key Market Drivers   To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions


TABLE OF CONTENTS
1 REPORT PROLOGUE

2 MARKET INTRODUCTION

2.1 INTRODUCTION

2.2 SCOPE OF STUDY

2.3 RESEARCH OBJECTIVE

2.4 ASSUMPTIONS & LIMITATIONS

2.4.1 ASSUMPTIONS

2.4.2 LIMITATIONS


3 RESEARCH METHODOLOGY

3.1 RESEARCH PROCESS

3.2 PRIMARY RESEARCH

3.3 SECONDARY RESEARCH

4 MARKET DYNAMICS

4.1 DRIVERS

4.2 RESTRAINS

4.3 OPPORTUNITIES
4.4 CHALLENGES

5 MARKET FACTOR ANALYSIS

5.1 PORTER’S FIVE FORCES MODEL

5.1.1 BARGAINING POWER OF SUPPLIERS

5.1.2 BARGAINING POWER OF BUYERS

5.1.3 THREAT OF NEW ENTRANTS

5.1.4 THREAT OF SUBSTITUTES

5.1.5 INTENSITY OF RIVALRY

5.2 SUPPLY CHAIN ANALYSIS

6 GLOBAL SURGICAL CHIPS MARKET, BY TYPES

6.1 DNA CHIPS

6.2 BRAIN CHIPS
6.3 LAB CHIPS
6.4 PROTEIN CHIPS
6.5 TISSUE CHIP

7 GLOBAL SURGICAL CHIPS MARKET, BY APPLICATION

7.1 CANCER DIAGNOSIS AND TREATMENT

7.2 GENE EXPRESSION

7.3 SNP GENOTYPING
7.4 GENOMICS
7.5 CLINICAL DIAGNOSTICS
7.6 OTHERS

8 GLOBAL SURGICAL CHIPS MARKET, BY END USER

8.1 HOSPITALS

8.2 RESEARCH CENTERS
8.3 OTHERS

9 GLOBAL SURGICAL CHIPS MARKET, BY REGION

9.1 INTRODUCTION
9.2 MARKET SIZE BY REGION
9.2.1 AMERICAS
9.2.1.1 NORTH AMERICA
9.2.1.1.1 US
9.2.1.1.2 CANADA
9.2.1.2 SOUTH AMERICA
9.2.2 EUROPE
9.2.2.1 WESTERN EUROPE
9.3.2.1.1 GERMANY
9.3.2.1.2 FRANCE
9.3.2.1.3 ITALY
9.3.2.1.4 SPAIN
9.3.2.1.5 UK
9.2.2.2 EASTERN EUROPE
9.2.3 ASIA-PACIFIC
9.2.3.1 ASIA
9.2.3.1.1 CHINA
9.2.3.1.2 INDIA
9.2.3.1.3 JAPAN
9.2.3.1.4 RUPUBLIC OF SOUTH KOREA
9.2.3.2 PACIFIC
9.4 MIDDLE EAST & AFRICA
9.4.1 MIDDLE EAST
9.4.1.1 UAE
9.4.1.2 SAUDI ARABIA
9.4.2 AFRICA
.4.2.1 EGYPT
9.4.3 REST OF MIDDLE EAST AND AFRICA

10 COMPANY PROFILE

10.1 Allied Healthcare Products
10.1.1 OVERVIEW

10.1.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

10.1.3 FINANCIAL UPDATES

10.1.4 KEY DEVELOPMENTS

10.2 Becton, Dickinson and Company

10.2.1 OVERVIEW

10.2.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

10.2.3 FINANCIAL UPDATES

10.2.4 KEY DEVELOPMENTS

10.3 Drägerwerk AG & Co. KGaA

10.3.1 OVERVIEW

10.3.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

10.3.3 FINANCIAL UPDATES
10.3.4 KEY DEVELOPMENTS

10.4 GE Healthcare

10.4.1 OVERVIEW

10.4.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

10.4.3 FINANCIAL UPDATES
10.4.4 KEY DEVELOPMENTS

10.5 Getinge Group

10.5.1 OVERVIEW

10.5.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

10.5.3 FINANCIAL UPDATES

10.5.4 KEY DEVELOPMENTS

10.6 Hamilton Medical AG

10.6.1 OVERVIEW

10.6.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

10.6.3 FINANCIAL UPDATES

10.6.4 KEY DEVELOPMENTS

10.7 Medtronic

10.7.1 COMPANY OVERVIEW

10.7.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

10.7.3 FINANCIAL UPDATES

10.7.4 KEY DEVELOPMENT

10.8 Philips Healthcare

10.8.1 OVERVIEW

10.8.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

10.8.3 FINANCIAL OVERVIEW

10.8.4 KEY DEVELOPMENT
10.9 ResMed
10.9.1 COMPANY OVERVIEW

10.9.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

10.9.3 FINANCIAL UPDATES

10.9.4 KEY DEVELOPMENT
10.10 Smiths Group plc

10.10.1 OVERVIEW

10.10.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

10.10.3 FINANCIAL OVERVIEW

10.10.4 KEY DEVELOPMENT
10.11 Teleflex Incorporated
10.11.1 COMPANY OVERVIEW

10.11.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

10.11.3 FINANCIAL UPDATES

10.11.4 KEY DEVELOPMENT

10.12 OTHERS


11. CONCLUSION
11.1 KEY Findings
11.1.1 FROM CEO’S VIEWPOINT
11.1.2 UNMET NEEDS OF THE MARKET
11.2 KEY COMPANIES TO WATCH
11.3 PREDICTION OF SURGICAL CHIPS MARKET
12. APPENDIX